• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病患者运动期间QT间期的反常延长:细胞机制及其对舒张功能的影响

Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function.

作者信息

Coppini Raffaele, Beltrami Matteo, Doste Ruben, Bueno-Orovio Alfonso, Ferrantini Cecilia, Vitale Giulia, Pioner Josè Manuel, Santini Lorenzo, Argirò Alessia, Berteotti Martina, Mori Fabio, Marchionni Niccolò, Stefàno Pierluigi, Cerbai Elisabetta, Poggesi Corrado, Olivotto Iacopo

机构信息

Department NeuroFarBa, University of Florence, Viale G. Pieraccini 6, 50139 Florence, Italy.

Cardiomyopathy Unit, Careggi University Hospital, Largo Brambilla 3, 50134 Firenze, Italy.

出版信息

Eur Heart J Open. 2022 May 10;2(3):oeac034. doi: 10.1093/ehjopen/oeac034. eCollection 2022 May.

DOI:10.1093/ehjopen/oeac034
PMID:35919344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9242073/
Abstract

AIMS

Ventricular cardiomyocytes from hypertrophic cardiomyopathy (HCM) patient hearts show prolonged action potential duration (APD), impaired intracellular Ca homeostasis and abnormal electrical response to beta -adrenergic stimulation. We sought to determine whether this behaviour is associated with abnormal changes of repolarization during exercise and worsening of diastolic function, ultimately explaining the intolerance to exercise experienced by some patients without obstruction.

METHODS AND RESULTS

Non-obstructive HCM patients (178) and control subjects (81) underwent standard exercise testing, including exercise echocardiography. Ventricular myocytes were isolated from myocardial samples of 23 HCM and eight non-failing non-hypertrophic surgical patients. The APD shortening in response to high frequencies was maintained in HCM myocytes, while β-adrenergic stimulation unexpectedly prolonged APDs, ultimately leading to a lesser shortening of APDs in response to exercise. In HCM vs. control subjects, we observed a lesser shortening of QT interval at peak exercise (QTc: +27 ± 52 ms in HCM, -4 ± 50 ms in controls,  < 0.0001). In patients showing a marked QTc prolongation (>30 ms), the excessive shortening of the electrical diastolic period was linked with a limited increase of heart-rate and deterioration of diastolic function at peak effort.

CONCLUSIONS

Abnormal balance of Ca- and K-currents in HCM cardiomyocytes determines insufficient APD and Ca-transient shortening with exercise. In HCM patients, exercise-induced QTc prolongation was associated with impaired diastolic reserve, contributing to the reduced exercise tolerance. Our results support the idea that severe electrical cardiomyocyte abnormalities underlie exercise intolerance in a subgroup of HCM patients without obstruction.

摘要

目的

肥厚型心肌病(HCM)患者心脏的心室心肌细胞表现出动作电位时程(APD)延长、细胞内钙稳态受损以及对β-肾上腺素能刺激的电反应异常。我们试图确定这种行为是否与运动期间复极化的异常变化以及舒张功能恶化有关,最终解释一些无梗阻患者运动不耐受的原因。

方法与结果

178例非梗阻性HCM患者和81例对照者接受了标准运动试验,包括运动超声心动图检查。从23例HCM患者和8例非衰竭非肥厚性手术患者的心肌样本中分离出心室肌细胞。HCM心肌细胞对高频刺激的APD缩短得以维持,而β-肾上腺素能刺激意外地延长了APD,最终导致运动时APD缩短幅度较小。与对照组相比(HCM组与对照组),我们观察到运动高峰时QT间期缩短幅度较小(校正QTc:HCM组为+27±52 ms,对照组为-4±50 ms,P<0.0001)。在QTc明显延长(>30 ms)的患者中,电舒张期过度缩短与运动高峰时心率增加受限和舒张功能恶化有关。

结论

HCM心肌细胞中钙电流和钾电流的异常平衡决定了运动时APD和钙瞬变缩短不足。在HCM患者中,运动诱导的QTc延长与舒张储备受损有关,导致运动耐量降低。我们的结果支持这样一种观点,即严重的心肌细胞电异常是HCM无梗阻亚组患者运动不耐受的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/66e3ab1a85ca/oeac034il1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/2bb9bd3f90d7/oeac034ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/3c504cb1c541/oeac034f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/bb2ea3262c16/oeac034f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/7b04c1f40a7d/oeac034f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/9048b4392f41/oeac034f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/ef75436b81cb/oeac034f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/4735abe21f2a/oeac034f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/66e3ab1a85ca/oeac034il1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/2bb9bd3f90d7/oeac034ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/3c504cb1c541/oeac034f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/bb2ea3262c16/oeac034f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/7b04c1f40a7d/oeac034f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/9048b4392f41/oeac034f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/ef75436b81cb/oeac034f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/4735abe21f2a/oeac034f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ea1/9242073/66e3ab1a85ca/oeac034il1.jpg

相似文献

1
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function.肥厚型心肌病患者运动期间QT间期的反常延长:细胞机制及其对舒张功能的影响
Eur Heart J Open. 2022 May 10;2(3):oeac034. doi: 10.1093/ehjopen/oeac034. eCollection 2022 May.
2
Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy.β肾上腺素刺激致肥厚型心肌病心律失常性动作电位时程延长与钾电流重构有关。
J Mol Cell Cardiol. 2022 Nov;172:120-131. doi: 10.1016/j.yjmcc.2022.08.361. Epub 2022 Sep 2.
3
Altered Ca and Na Homeostasis in Human Hypertrophic Cardiomyopathy: Implications for Arrhythmogenesis.人类肥厚型心肌病中钙和钠稳态的改变:对心律失常发生机制的影响。
Front Physiol. 2018 Oct 16;9:1391. doi: 10.3389/fphys.2018.01391. eCollection 2018.
4
Systolic function reserve using two-dimensional strain imaging in hypertrophic cardiomyopathy: comparison with essential hypertension.二维应变成像技术评估肥厚型心肌病与原发性高血压患者左室收缩功能储备的对比研究。
J Am Soc Echocardiogr. 2013 Dec;26(12):1397-406. doi: 10.1016/j.echo.2013.08.026. Epub 2013 Oct 3.
5
Remodeling of repolarization and arrhythmia susceptibility in a myosin-binding protein C knockout mouse model.肌球蛋白结合蛋白C基因敲除小鼠模型中的复极重塑与心律失常易感性
Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H620-H630. doi: 10.1152/ajpheart.00167.2017. Epub 2017 Jun 23.
6
Impaired left ventricular mechanics and functional reserve are associated with reduced exercise capacity in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者左心室力学和功能储备受损与运动能力下降有关。
Echocardiography. 2019 Feb;36(2):266-275. doi: 10.1111/echo.14241. Epub 2019 Jan 1.
7
Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy.晚期钠电流抑制可逆转人类肥厚型心肌病的机电功能障碍。
Circulation. 2013 Feb 5;127(5):575-84. doi: 10.1161/CIRCULATIONAHA.112.134932. Epub 2012 Dec 27.
8
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits.动作电位时程与舒张功能障碍在转基因和药物诱导的长 QT2 兔中的空间相关性。
Heart Rhythm. 2013 Oct;10(10):1533-41. doi: 10.1016/j.hrthm.2013.07.038. Epub 2013 Jul 26.
9
Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.地尔硫卓可预防应激诱导的心肌细胞收缩功能缺陷,但不能逆转Mybpc3基因敲入小鼠的心肌病表型。
J Physiol. 2017 Jun 15;595(12):3987-3999. doi: 10.1113/JP273769. Epub 2017 Feb 7.
10
Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.诱导多能干细胞衍生的肥厚型心肌病患者心肌细胞舒张功能障碍建模。
Eur Heart J. 2019 Dec 1;40(45):3685-3695. doi: 10.1093/eurheartj/ehz326.

引用本文的文献

1
The many faces of SCN5A pathogenic variants: from channelopathy to cardiomyopathy.SCN5A致病变体的多样表现:从通道病到心肌病
Heart Fail Rev. 2025 Jan;30(1):247-256. doi: 10.1007/s10741-024-10459-x. Epub 2024 Oct 28.
2
Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy.应激心电图中肥厚型心肌病 T 波假性正常化的电生理机制。
Comput Biol Med. 2024 Feb;169:107829. doi: 10.1016/j.compbiomed.2023.107829. Epub 2023 Dec 7.
3
Multimodality Imaging in Sarcomeric Hypertrophic Cardiomyopathy: Get It Right…on Time.

本文引用的文献

1
In-silico human electro-mechanical ventricular modelling and simulation for drug-induced pro-arrhythmia and inotropic risk assessment.基于计算机的人心室机电建模与仿真在药物致心律失常和变力性风险评估中的应用。
Prog Biophys Mol Biol. 2021 Jan;159:58-74. doi: 10.1016/j.pbiomolbio.2020.06.007. Epub 2020 Jul 22.
2
Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: A Translational Study.丙吡胺对梗阻性肥厚型心肌病患者的电生理及收缩效应:一项转化医学研究
JACC Basic Transl Sci. 2019 Oct 9;4(7):795-813. doi: 10.1016/j.jacbts.2019.06.004. eCollection 2019 Nov.
3
肌节性肥厚型心肌病的多模态成像:及时准确诊断。
Life (Basel). 2023 Jan 6;13(1):171. doi: 10.3390/life13010171.
Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block.
新型健康、疾病和药物阻滞人心室肌细胞模型的开发、校准和验证。
Elife. 2019 Dec 24;8:e48890. doi: 10.7554/eLife.48890.
4
Late sodium current inhibitors to treat exercise-induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium.晚期钠电流抑制剂治疗肥厚型心肌病运动诱发梗阻:人类心肌的体外研究。
Br J Pharmacol. 2018 Jul;175(13):2635-2652. doi: 10.1111/bph.14223. Epub 2018 May 3.
5
Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.肥厚型心肌病的发病机制是突变而非疾病特异性:心肌肌钙蛋白T E163R和R92Q小鼠模型的比较
J Am Heart Assoc. 2017 Jul 22;6(7):e005407. doi: 10.1161/JAHA.116.005407.
6
Dissecting functional impairment in hypertrophic cardiomyopathy by dynamic assessment of diastolic reserve and outflow obstruction: A combined cardiopulmonary-echocardiographic study.通过舒张储备和流出道梗阻的动态评估剖析肥厚型心肌病的功能损害:一项心肺超声心动图联合研究
Int J Cardiol. 2017 Jan 15;227:743-750. doi: 10.1016/j.ijcard.2016.10.067. Epub 2016 Oct 28.
7
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.超声心动图评估左心室舒张功能的建议:美国超声心动图学会和欧洲心血管影像学会的更新
Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1321-1360. doi: 10.1093/ehjci/jew082. Epub 2016 Jul 15.
8
Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.人类肥厚型心肌病中心室复极促心律失常异常的机制及抗心律失常治疗
J Mol Cell Cardiol. 2016 Jul;96:72-81. doi: 10.1016/j.yjmcc.2015.09.003. Epub 2015 Sep 16.
9
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).2014年欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗指南:欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗工作组
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
10
Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.肥厚型心肌病:现状与未来,融入当代心血管医学。
J Am Coll Cardiol. 2014 Jul 8;64(1):83-99. doi: 10.1016/j.jacc.2014.05.003.